US 9896509
Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
granted A61KA61K2039/505A61K38/12
Quick answer
US patent 9896509 (Use of antagonists of the interaction between HIV GP120 and α4β7 integrin) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K38/12, A61K39/3955, A61K45/06